| Product NDC: | 0703-7041 |
| Proprietary Name: | Haloperidol |
| Non Proprietary Name: | Haloperidol |
| Active Ingredient(s): | 5 mg/mL & nbsp; Haloperidol |
| Administration Route(s): | INTRAMUSCULAR |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0703-7041 |
| Labeler Name: | Teva Parenteral Medicines, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076035 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20020301 |
| Package NDC: | 0703-7041-04 |
| Package Description: | 25 VIAL, SINGLE-DOSE in 1 TRAY (0703-7041-04) > 1 mL in 1 VIAL, SINGLE-DOSE (0703-7041-01) |
| NDC Code | 0703-7041-04 |
| Proprietary Name | Haloperidol |
| Package Description | 25 VIAL, SINGLE-DOSE in 1 TRAY (0703-7041-04) > 1 mL in 1 VIAL, SINGLE-DOSE (0703-7041-01) |
| Product NDC | 0703-7041 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Haloperidol |
| Dosage Form Name | INJECTION |
| Route Name | INTRAMUSCULAR |
| Start Marketing Date | 20020301 |
| Marketing Category Name | ANDA |
| Labeler Name | Teva Parenteral Medicines, Inc. |
| Substance Name | HALOPERIDOL LACTATE |
| Strength Number | 5 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Typical Antipsychotic [EPC] |